# 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

> **NCT00398580** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 43 (actual)

## Conditions studied

- Hypogonadism
- Hypogonadism, Male

## Interventions

- **DRUG:** Nanomilled testosterone
- **DRUG:** Nanomilled dutasteride
- **DRUG:** commercially available dutasteride

## Key facts

- **NCT ID:** NCT00398580
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398580, "28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00398580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*